clinical trial · NCT06579573
ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
Ono Pharmaceutical Co., Ltd.·phase3·recruiting·n = 15
Epilepsy, GeneralizedCenobamate
brief summary
To investigate the efficacy and safety of ONO-2017 in combination with antiepileptics in Japanese epileptic patients with generalized tonic-clonic seizures.
started
Jul 12, 2022
primary completion
Jan 31, 2027
completion
Jan 31, 2027
last updated
Jun 17, 2025
official title
ONO-2017 Phase III Study A Multicenter, Open-label Study in Japanese Patients With Primary Generalized Tonic Clonic Seizures.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol